Significant changes in CCL22 and CCL28 in the online breast cancer data sets also showed decreased tumor expression (Supplementary information, Table S4), suggesting that these chemokines are unlikely to play an important role in Treg recruitment to breast cancer. The gene discussed is CCL28; the disease is breast carcinoma.